Özlem GÜLBAHAR, Nigar AFANDIYEVA, Feride AYYILDIZ, Hilal YILDIRAN, Oğuz KÖKTÜRK

The effects of vitamin D supplemantation on prognosis in patients with mild obstructive sleep apnea syndrome

Background/aim: The aim of this study was to investigate the effect of vitamin D on the disease prognosis and biochemical parameters in patients with mild obstructive sleep apnea syndrome (OSAS). Materials and methods: Nineteen adult male individuals (18–65 years) who were diagnosed with mild OSAS after polysomnography and had low vitamin D levels were included in the study. Each week, patients took 50.000 IU Vitamin D3 supplementation for 8 weeks. Polysomnography, biochemical parameters FBG (fasting blood glucose), lipid profile (TG, TC, LDL-C, HDL-C, VLDL-C), calcium, phosphorus, parathormone, calcitonin, serum 25(OH)D, insulin, CRP, TNF-α, IL-6, and IL-10 of patients were evaluated at the beginning of study and at the end of the study. All assessments, including polysomnography, were repeated after 8 weeks. Results: Serum vitamin D levels were initially 19.5 ± 5.01 ng/mL and increased to 41.8 ± 10.51 ng/mL (p < 0.001) at the end of the study. FBG, TC and HOMA-IR of the patients were significantly decreased (p < 0.05). CRP, TNF-α, IL-6, and IL-10 levels were also correlated with serum vitamin D levels (p < 0.05). There was a significant decrease in number of obstructive apneas, apneas and hypopneas, apnea index, hypopnea index, and apnea hypopnea index of the patients (p < 0.05). Conclusion: As a result, it is thought that vitamin D supplementation may have a positive effect on the disease prognosis of mild OSAS.Key words: Vitamin D supplementation, obstructive sleep apnea, biochemical parameters, inflammation

PDF

___

1. Hong S, Chen YF, Jung Y, Kwon YD, Liu SYC. Hypoglossal nerve stimulation for treatment of obstructive sleep apnea (OSA): a primer for oral and maxillofacial surgeons. Maxillofacial Plastic and Reconstructive Surgery 2017; 39: 27. doi: 10.1186/s40902-017-0126-0
2. Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A et al. Clinical guideline for the evaluation, management and longterm care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine 2009; 5 (3): 263-276.
3. Cowie MR. Sleep apnea: state of the art. Trends in Cardiovascular Medicine 2017; 27 (4): 280-289. doi: 10.1016/j.tcm.2016.12.005
4. Neighbors CL, Noller MW, Song SA, Zaghi S, Neighbors J et al. Vitamin D and obstructive sleep apnea: a systematic review and meta-analysis. Sleep Medicine 2017; 43 (1): 100-108. doi: 10.1016/j.sleep.2017.10.016
5. Köktürk O, Ulukavak Çiftçi T, Mollarecep E, Çiftçi B. Elevated Creactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. International Heart Journal 2005; 46: 801-809. doi: 10.1536/ihj.46.801
6. Alberti A, Sarchielli P, Gallinella E, Floridi A, Floridi A et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. Journal of Sleep Research 2003; 12 (4): 305-311. doi: 10.1111/j.1365- 2869.2003.00361.x
7. Sniderman AD, Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arteriosclerosis, Thrombosis, and Vascular Biology 1993; 13 (5): 629-636. doi: 10.1161/01.atv.13.5.629
8. Köktürk O, Kanbay A. Insulin resistance in patients with obstructive sleep apnea syndrome. Eurasian Journal of Pulmonology 2003; 15 (2): 135-136. doi: 10.5152/solunum.2013.027
9. Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D et al. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 2006; 29 (2): 240-243. doi: 10.1093/sleep/29.2.240
10. Demir A, Ursavaş A, Tana Aslan A, Gülbay B, Çiftçi B et al. Türk Toraks Derneği Obstrüktif Uyku Apne Sendromu Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Dergisi 2012; 13 (Suppl 1): 1-73 (in Turkish).
11. Huang YC, Lin CY, Lan CC, Wu YK, Lim CS et al. Comparison of cardiovascular co-morbidities and CPAP use in patients with positional and non-positional mild obstructive sleep apnea. BMC Pulmonary Medicine 2014; 14 (1): 140-153. doi: 10.1186/1471-2466-14-153
12. Budhiraja R, Budhiraja P, Quan SF. Sleep-disordered breathing and cardiovascular disorders. Respiratory Care 2010; 55 (10): 1322-1332.
13. McCarty DE, Chesson AL, Jain SK, Marino AA. The link between vitamin D metabolism and sleep medicine. Sleep Medicine Reviews 2014; 18 (4): 311-319. doi: 10.1016/j.smrv.2013.07.001
14. Upala S, Sanguankeo A. Association between 25- hydroxyvitamin D and obstructive sleep apnea: a systematic review and meta-analysis. Journal of Clinical Sleep Medicine 2015; 11 (11): 1347-1347. doi: 10.5664/jcsm.5208
15. Mete T, Yalcin Y, Berker D, Ciftci B, Guven S et al. Obstructive sleep apnea syndrome and its association with vitamin D deficiency. Journal of Endocrinological Investigation 2013; 36 (9): 681-685. doi: 10.3275/8923
16. Erden ES, Genc S, Ustun I, Ulutas KT, Bilgic HK et al. Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome. Endocrine 2014; 45 (2): 311-318. doi: 10.1007/s12020-013-0022-z
17. Kerley CP, Hutchinson K, Bolger K, McGowan A, Faul J et al. Serum vitamin D is significantly inversely associated with disease severity in Caucasian adults with obstructive sleep apnea syndrome. Sleep 2016; 39 (2): 293-300. doi: 10.5665/sleep.5430
18. Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007; 30 (9): 1145-1152. doi: 10.1093/sleep/30.9.1145
19. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? British Journal of Nutrition 2003; 89 (5): 552-572. doi: 10.1079/BJN2003837
20. De Vita F, Lauretani F, Bauer J, Bautmans I, Shardell M et al. Relationship between vitamin D and inflammatory markers in older individuals. Age 2014; 36 (4): 9694. doi: 10.1007/s11357-014-9694-4
21. Liefaard MC, Ligthart S, Vitezova A, Hofman A, Uitterlinden AG et al. Vitamin D and C-reactive protein: a Mendelian randomization study. PloS One 2015; 10 (7): e0131740. doi: 10.1371/journal.pone.0131740
22. Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF et al. CPAP versus oxygen in obstructive sleep apnea. New England Journal of Medicine 2014; 370 (24): 2276-2285. doi: 10.1056/NEJMoa1306766
23. Stradling J, Craig S, Kohler M, Nicoll D, Ayers L et al. Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA. Thorax 2015; 70 (2): 181- 182. doi: 10.1136/thoraxjnl-2014-205958
24. Hudgel DW. Critical review: CPAP and weight management of obstructive sleep apnea cardiovascular co-morbidities. Sleep Medicine Reviews 2016; 37: 14-23. doi: 10.1016/j.smrv.2016.12.001
25. Ruehland WR, Rochford PD, O’donoghue FJ, Pierce RJ, Singh P et al. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 2009; 32 (2): 150-157. doi: 10.1093/sleep/32.2.150
26. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanle DA et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2011; 96 (7): 1911-1930. doi: 10.1210/jc.2011-0385
27. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21 (12): 2191-2192. doi: 10.2337/diacare.21.12.2191
28. Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine 2017; 13 (3): 479-504. doi: 10.5664/jcsm.6506
29. Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006; 29 (3): 375-380. doi: 10.1093/sleep/29.3.375
30. Li X, He J, Yun J. The association between serum vitamin D and obstructive sleep apnea: an updated meta-analysis. Respiratory Research 2020; 21: 294. doi: 10.1186/s12931- 020-01554-2
31. Liguori C, Romigi A, Izzi F, Mercuri NB, Cordella A et al. Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea. Journal of Clinical Sleep Medicine 2015; 11 (6): 603- 607. doi: 10.5664/jcsm.4766
32. Verrusio W, Andreozzi P, Renzi A, Musumeci M, Gueli N et al. Association between serum vitamin D and metabolic syndrome in middle-aged and older adults and role of supplementation therapy with vitamin D. Annali Dell'ıstituto Superiore Di Sanita 2017; 53 (1): 54-59. doi: 10.4415/ANN_17_01_11
33. Şahin M. Soru 1–Kolesterol hipotezi nedir? Kardiyovasküler hastalıklara neden oluyor mu? Bu konuda elimizdeki kanıtlar nelerdir? Turk Kardiyoloji Derneği Arşivi 2016; 44 (4): 1-141 (in Turkish).
34. Kerley CP, Hutchinson K, Bramham J, McGowan A, Faul J et al. Vitamin D improves selected metabolic parameters but not neuropsychological or quality of life indices in OSA: a pilot study. Journal of Clinical Sleep Medicine 2017; 13 (1): 19-26. doi: 10.5664/jcsm.6378
35. Nadeem R, Singh M, Nida M, Kwon S, Sajid H et al. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. Journal of Clinical Sleep Medicine 2014; 10 (12): 1295-1302. doi: 10.5664/jcsm.4282
36. Barbalho SM, Tofano RJ, De Campos AL, Rodrigues AS, Quesada K et al. Association between vitamin D status and metabolic syndrome risk factors. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12 (4): 501-507. doi: 10.1016/j.dsx.2018.03.011
37. Leon-Cabrera S, Arana-Lechuga Y, Esqueda-León E, TeránPérez G, Gonzalez-Chavez A et al. Reduced systemic levels of IL10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans. Mediators of Inflammation 2015; 2015: 493409. doi: 10.1155/2015/493409
38. Bozkurt NC, Cakal E, Sahin M, Ozkaya EC, Firat H et al. The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine 2012; 41 (3): 518-525. doi: 10.1007/s12020-012-9595-1
39. Karefylakis C, Särnblad S, Ariander A, Ehlersson G, Rask E et al. Effect of Vitamin D supplementation on body composition and cardiorespiratory fitness in overweight men-a randomized controlled trial. Endocrine 2018; 61 (3): 388-397. doi: 10.1007/s12020-018-1665-6
40. Osati S, Homayounfar R, Hajifaraji M. Metabolic effects of vitamin D supplementation in vitamin D deficient patients (a double-blind clinical trial). Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2016; 10 (2): 7-10. doi: 10.1016/j.dsx.2016.01.007
41. Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M. Longterm compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Canadian Respiratory Journal 2008; 15 (7): 365-369. doi: 10.1155/2008/534372.
42. Balbani AP, Weber SA, Montovani JC. Update in obstructive sleep apnea syndrome in children. Revista Brasileira de Otorrinolaringologia 2005; 71 (1): 74-80. doi: 10.1016/s1808- 8694(15)31288-x
43. Lakadamyalı H, Fıratgüven S, Çiftçi B, Eyüboğlu FÖ. Hızlı göz hareketleri ile ilişkili obstrüktif uyku apnesendromu: antropometrik ve polisomnografik bulgular. Tuberküloz ve Toraks Dergisi 2012; 60 (1): 13-19 (in Turkish).
44. Oksenberg A, Arons E, Radwan H, Silverberg DS. Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic and multiple sleep latency test data. Chest 1997; 112 (3): 629-639. doi: 10.1378/chest.112.3.629
45. Isono S, Tanaka A, Nishino T. Lateral position decreases collapsibility of the passive pharynx in patients with obstructive sleep apnea. Anesthesiology: The Journal of the American Society of Anesthesiologists 2002; 97 (4): 780-785. doi: 10.1097/00000542-200210000-00006
46. Iftikhar IH, Bittencourt L, Youngsted SD, Ayas N, Cistulli P et al. Comparative efficacy of CPAP, MADs, exercise-training, and dietary weight loss for sleep apnea: a network meta-analysis. Sleep Medicine 2017; 30 (1): 7-14. doi: 10.1016/j.sleep.2016.06.001
47. Nerfeld P, Nilsson BY, Mayor L, Uddé J, Friberg D. A two-year weight reduction program in obese sleep apnea patients. Journal of Clinical Sleep Medicine 2010; 6 (5): 479-486.